Ad
related to: myotonic dystrophy type iiBrowse & Discover Thousands of Medicine Book Titles, for Less.
Search results
People also ask
What is myotonic dystrophy type 1 & 2?
What is myotonic dystrophy type 2 (DM2)?
What causes myotonic dystrophy type 2?
Dec 12, 2022 · Myotonic dystrophy is a genetic condition that affects muscle function and causes myotonia. Learn about the two main types of myotonic dystrophy (DM1 and DM2), their differences, symptoms, causes and treatment options.
Dec 1, 2020 · Myotonic dystrophy type 2 scored significantly lower than myotonic dystrophy type 1 on the bodily pain scale, indicating more body pain in myotonic dystrophy type 2. This finding has a high disease impact on physical as well as on mental health functioning 71 , and on professional performance 72 .
- Giovanni Meola
- 10.36185/2532-1900-026
- 2020
- Acta Myol. 2020 Dec; 39(4): 222-234.
Learn about the causes, symptoms, and progression of myotonic dystrophy, a form of muscular dystrophy that affects muscles and many other organs. Find out the differences between type 1 and type 2 DM, and the current research on possible treatments.
Type 2 (DM2), also known as proximal myotonic myopathy (PROMM), is rarer and generally manifests with milder signs and symptoms than DM1. Other forms of myotonic dystrophy not associated with DM1 or DM2 genetic mutations have been described.
Sep 21, 2006 · Myotonic dystrophy type 2 (DM2) is characterized by myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness), and less commonly by posterior subcapsular cataracts, cardiac conduction defects, insulin-insensitive type 2 diabetes mellitus, and other endocrine abnormalities.
- Benedikt Schoser
- 2020/03/19
- 2020
Mar 19, 2024 · Learn about myotonic dystrophy, a genetic condition that affects muscle strength and tone. Find out the differences between types 1 and 2, how they are diagnosed and treated, and their prevalence and complications.
Mar 15, 2024 · Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are autosomal dominant, multisystem disorders characterized by skeletal muscle weakness and myotonia, cardiac conduction abnormalities, iridescent cataracts, and other abnormalities. The management and prognosis of patients with DM will be reviewed here.